Optinose Inc (OPTN) Quarterly Balance Sheets

Quarterly · GAAP · USD millions
Access OPTN Annual Balance Sheets →
This balance sheet overview for Optinose Inc spans from Mar 31 2024 to Mar 31 2025, showing how the company's assets, liabilities, and equity have evolved across reporting periods.
Quarterly Report, GAAP in USD millions
ITEM
(Mar 31 2025)
(Dec 31 2024) (Sep 30 2024) (Jun 30 2024) (Mar 31 2024)
Assets
Cash & cash equivalent72.93
Cash & Short-term Investments72.00
Accounts receivable23.14
Inventories11.30
Other Current Assets0.00
Prepaid Expense And Other Assets Current4.63
Total Current Assets112.01
Equipment/Property/Plant Net0.54
Other Assets, Noncurrent2.00
Total Assets114.85
Liabilities
Accounts Payable, Current AC1.42
Derivative Liability, Current DE8.76
Short-term Debt DE1127.21
Other Liabilities, Current37.62
Total Current Liabilities175.01
Long-term debt0.00
Total Long-term Debt0.00
Other liabilities, Noncurrent1.21
Warrant Liability Current6.90
Warrant Liability Noncurrent-
Warrant Liability Non Current-
Total Liabilities176.22
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock703.04
Retained Earnings / Accumulated Deficit-764.33
Other Equity-0.08
Common Stockholder's Equity-61.37
Total Stockholder's Equity-61.37
Liabilities & Stockholder's Equity114.85
4 historic quarters locked

Sign in to unlock the full Optinose Inc balance sheet history.

About Optinose Inc Quarterly Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-Q filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001494650-25-000072

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.